HMGB1 and columnar cell hyperplasia of the breast: This is the first study to use modified bilateral common carotid artery occlusion (BCCAO) to induce CCH in mice and suppress the HMGB1 level with the CRISPR/Cas9 knockout (KO) plasmid during the chronic stage.